Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC (AGN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Sector news Pharmaceuticals - NEC
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
04/21TAKEDA PHARMACEUTICAL : Keeps Courting Shire -- WSJ
DJ
04/20GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
04/20Japan's Takeda sweetens $62 billion Shire offer
RE
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From -2-
DJ
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From Takeda Pharmaceutical Company L..
DJ
04/20Generics group Alvogen puts Eastern European operations up for sale - sources
RE
04/20P&G's vitamin boost could signal more to come
RE
04/20TAKEDA PHARMACEUTICAL : ups Shire offer to 47 pounds-a-share
RE
04/20TAKEDA PHARMACEUTICAL : Statement -2-
DJ
04/20TAKEDA PHARMACEUTICAL : Statement Regarding Improved Proposal for Shire
DJ
04/20INVESCO UK LTD INVESCO LTD. : Form 8.3 - Shire Plc
DJ
04/20TAKEDA PHARMACEUTICAL : weighs raising Shire bid to more than 47 pounds per shar..
RE
04/20MONSANTO : Russian nod moves Bayer closer to wrapping up Monsanto deal
RE
04/20BAYER : Gains Russian Approval for Monsanto Deal
DJ
04/20RUSSIA GIVES GREEN LIGHT TO BAYER'S : Ifax
RE
04/20Shire Attracts Flurry Of Suitors -- WSJ
DJ
04/20Corrections & Amplifications -- WSJ
DJ
04/20SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
04/20SHIRE : Allergan PLC Statement regarding Shire plc
DJ
04/20JPMorgan, National Bank of Canada, others test debt issuance on blockchain
RE
04/19Shire rejects $63 billion Takeda bid as Allergan drops pursuit
RE
04/19Shire rejects $63 billion Takeda bid as Allergan drops pursuit
RE
04/19Shire rejects $63 billion Takeda bid as Allergan drops pursuit
RE
04/19EUROPE MARKETS : European Stocks Edge Up As Deal Developments, Earnings Reports ..
DJ
04/19EXCLUSIVE - ALLERGAN IN TALKS TO ACQ : sources
RE
04/19ALLERGAN : Statement Regarding Strategic Review
DJ
04/19P&G earnings beat as struggling retailers, costs eat into margins
RE
04/19SHIRE PLC SHIRE PLC : Statement Re Proposal From -3-
DJ
04/19SHIRE PLC SHIRE PLC : Statement Re Proposal From -2-
DJ
04/19SHIRE PLC SHIRE PLC : Statement Re Proposal From Takeda Pharmaceutical Company L..
DJ
04/19P&G earnings beat as struggling retailers, costs eat into margins
RE
04/19P&G earnings beat as struggling retailers, costs eat into margins
RE
04/19P&G Slogs Through 'Difficult' Markets for Sales Growth --Update
DJ
04/19Takeda makes $61 billion bid for drugmaker Shire - sources
RE
04/19TAKEDA PHARMACEUTICAL : Statement -2-
DJ
04/19TAKEDA PHARMACEUTICAL : Statement Regarding Shire plc
DJ
04/19P&G Slogs Through 'Difficult' Markets for Sales Growth
DJ
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/19TAKEDA MAKES $61 BILLION BID FOR DRU : sources
RE
04/19Correction to P&G to Acquire Merck KGaA's Consumer-Health Unit Article
DJ
04/19INVESCO UK LTD INVESCO LTD. : Form 8.3 - Shire Plc
DJ
04/19WHAT'S NEWS : Business & Finance -- WSJ
DJ
04/19NOVARTIS : 1Q Profit, Sales Rise, Buoyed by Heart Drug -- Update
DJ
04/19ASTRAZENECA : Cancer Drug Tagrisso Approved by FDA As First-Line Treatment
DJ
04/19NOVARTIS : 1Q Net Profit, Sales Grow
DJ
04/19P&G to Acquire Merck KGaA's Consumer-Health Unit -- 2d Update
DJ
04/19P&G Buys German Health Business -- WSJ
DJ
04/19P&G Nears Deal to Acquire Merck KGaA's Consumer-Health Unit -- Update
DJ
04/19P&G Nears Deal to Acquire Merck KGaA's Consumer-Health Unit
DJ
1  2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2018 15 225 M
EBIT 2018 7 285 M
Net income 2018 -908 M
Debt 2018 23 926 M
Yield 2018 1,84%
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 5,17x
EV / Sales 2019 4,83x
Capitalization 54 802 M
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ALLERGAN PLC-3.10%54 802
JOHNSON & JOHNSON-9.35%339 783
PFIZER1.13%217 897
NOVARTIS-7.67%204 972
ROCHE HOLDING LTD.-12.52%191 890
MERCK AND COMPANY4.55%158 571
AMGEN-1.35%114 648
ABBOTT LABORATORIES3.71%103 366
SANOFI-9.14%100 746
BAYER-4.81%100 586
GLAXOSMITHKLINE8.13%99 256
NOVO NORDISK A/S-15.04%92 039
ASTRAZENECA-2.83%88 255
ELI LILLY AND COMPANY-6.39%86 389
BRISTOL-MYERS SQUIBB COMPANY-15.78%83 664
CELGENE CORPORATION-14.77%66 906
SHIRE-2.01%49 100
JIANGSU HENGRUI MEDICINE CO LTD21.82%37 816
TAKEDA PHARMACEUTICAL CO LTD-25.28%35 853
SAMSUNG BIOLOGICS CO LTD--.--%31 303
ASTELLAS PHARMA INC9.10%30 402